Related Experiment Video
Updated: Apr 15, 2026

Live Images of GLUT4 Protein Trafficking in Mouse Primary Hypothalamic Neurons Using Deconvolution Microscopy
Published on: December 7, 2017
Early Pregnancy Central Obesity and Risk of Prenatal and Postpartum Diabetes and Hypertensive Disorders
Ana K Rosen Vollmar1,2, Monique M Hedderson1, Amanda L Ngo1
1Division of Research, Kaiser Permanente Northern California, Pleasanton, CA.
Insights
Central obesity during pregnancy increases risks for gestational diabetes and postpartum hypertension, even with a healthy BMI. Early pregnancy central obesity measures improve cardiometabolic risk assessment beyond BMI alone.
Area of Science:
- Obstetrics and Gynecology
- Cardiology
- Endocrinology
Background:
- Body Mass Index (BMI) has limitations in assessing obesity.
- Central obesity's role in pregnancy and postpartum cardiometabolic conditions is understudied.
- Investigating central obesity independently and with BMI is crucial for risk assessment.
Purpose of the Study:
- To investigate associations between central obesity measures and perinatal cardiometabolic conditions.
- To evaluate central obesity's role independently and jointly with BMI.
- To determine if central obesity enhances risk prediction beyond BMI.
Main Methods:
- Examined early pregnancy central obesity measures (waist circumference, waist-to-hip ratio, waist-to-height ratio, body roundness index).
- Assessed associations with gestational diabetes mellitus, hypertensive disorders of pregnancy, postpartum prediabetes/diabetes, and postpartum chronic hypertension.
- Utilized modified Poisson and Cox regression models for outcome analysis.
Main Results:
- A dose-response relationship was observed between increasing central obesity and all cardiometabolic outcomes, independent of BMI.
- Individuals with healthy prepregnancy BMI and central obesity showed increased risk for gestational diabetes mellitus (RR 1.92-2.42).
- Central obesity was linked to higher risks of postpartum prediabetes/diabetes (HR 1.50-2.16) and chronic hypertension (HR 2.04-3.63).
Conclusions:
- Early pregnancy central obesity measures can enhance perinatal cardiometabolic risk assessment.
- Central obesity identifies individuals at risk who may be missed by BMI alone.
- Incorporating central obesity metrics improves identification of at-risk pregnancies.
Objective:
Despite limitations in using BMI to assess obesity, little is known about central obesity's role in pregnancy and postpartum cardiometabolic conditions. We investigated associations of central obesity with perinatal cardiometabolic conditions, independently and jointly with BMI.
Research Design And Methods:
We examined associations of early pregnancy central obesity measures (waist circumference, waist-to-hip ratio, waist-to-height ratio, and body roundness index) with gestational diabetes mellitus, hypertensive disorders of pregnancy, postpartum prediabetes/diabetes, and postpartum chronic hypertension using modified Poisson (prenatal outcomes) and Cox (postpartum outcomes) regression.
Results:
Among the 3,055 individuals in the study, there was a dose-response relationship between increasing central obesity and all outcomes, even after adjusting for BMI. Among individuals with healthy prepregnancy BMI, central obesity was associated with a higher risk of gestational diabetes mellitus (relative risks 1.92-2.42), postpartum prediabetes/diabetes (hazard ratios [HRs] 1.50-2.16), and postpartum chronic hypertension (HRs 2.04-3.63).
Conclusions:
Early pregnancy central obesity measures may enhance perinatal cardiometabolic risk assessment, helping identify at-risk individuals who could be missed using BMI alone.
Related Concept Videos
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Diabetes Mellitus: Type 2 and Gestational
Obesity
Diabetes: Symptoms, Diagnosis, and Complications
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Carbohydrate Metabolism
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...

